Literature DB >> 22674978

Interactions between proteins encoded within the human cytomegalovirus UL133-UL138 locus.

Alex Petrucelli1, Mahadevaiah Umashankar, Patricia Zagallo, Michael Rak, Felicia Goodrum.   

Abstract

We previously described a novel genetic locus within the ULb' region of the human cytomegalovirus (HCMV) genome that, while dispensable for replication in fibroblasts, suppresses replication in hematopoietic progenitors and augments replication in endothelial cells. This locus, referred to as the UL133-UL138 locus, encodes four proteins, pUL133, pUL135, pUL136, and pUL138. In this work, we have mapped the interactions among these proteins. An analysis of all pairwise interactions during transient expression revealed a robust interaction between pUL133 and pUL138. Potential interactions between pUL136 and both pUL133 and pUL138 were also revealed. In addition, each of the UL133-UL138 locus proteins self-associated, suggesting a potential to form higher-order homomeric complexes. As both pUL133 and pUL138 function in promoting viral latency in CD34(+) hematopoietic progenitor cells (HPCs) infected in vitro, we further focused on this interaction. pUL133 and pUL138 are the predominant complex detected when all proteins are expressed together and require no other proteins in the locus for their association. During infection, the interaction between pUL133 and pUL138 or pUL136 can be detected. A recombinant virus that fails to express both pUL133 and pUL138 exhibited a latency phenotype similar to that of viruses that fail to express either pUL133 or pUL138, indicating that these proteins function cooperatively in latency and do not have independent functions that additively contribute to HCMV latency. These studies identify protein interactions among proteins encoded by the UL133-UL138 locus and demonstrate an important interaction impacting the outcome of HCMV infection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22674978      PMCID: PMC3421763          DOI: 10.1128/JVI.00465-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

1.  An efficient recombination system for chromosome engineering in Escherichia coli.

Authors:  D Yu; H M Ellis; E C Lee; N A Jenkins; N G Copeland; D L Court
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

2.  Reevaluation of human cytomegalovirus coding potential.

Authors:  Eain Murphy; Isidore Rigoutsos; Tetsuo Shibuya; Thomas E Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-30       Impact factor: 11.205

3.  The cytomegalovirus-specific CD4+ T-cell response expands with age and markedly alters the CD4+ T-cell repertoire.

Authors:  Batoul Pourgheysari; Naeem Khan; Donna Best; Rachel Bruton; Laxman Nayak; Paul A H Moss
Journal:  J Virol       Date:  2007-04-04       Impact factor: 5.103

4.  The possible role of human cytomegalovirus (HCMV) in the origin of atherosclerosis.

Authors:  R Horváth; J Cerný; J Benedík; J Hökl; I Jelínková; J Benedík
Journal:  J Clin Virol       Date:  2000-02       Impact factor: 3.168

5.  Cytomegalovirus: pathogen, paradigm, and puzzle.

Authors:  Michael Boeckh; Adam P Geballe
Journal:  J Clin Invest       Date:  2011-05       Impact factor: 14.808

6.  Human cytomegalovirus genes in the 15-kilobase region are required for viral replication in implanted human tissues in SCID mice.

Authors:  Weijia Wang; Shannon L Taylor; Stacey A Leisenfelder; Robert Morton; Jennifer F Moffat; Sergey Smirnov; Hua Zhu
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

7.  The cytomegaloviral protein pUL138 acts as potentiator of tumor necrosis factor (TNF) receptor 1 surface density to enhance ULb'-encoded modulation of TNF-α signaling.

Authors:  Vu Thuy Khanh Le; Mirko Trilling; Hartmut Hengel
Journal:  J Virol       Date:  2011-10-05       Impact factor: 5.103

Review 8.  Do pathogens accelerate atherosclerosis?

Authors:  D N Streblow; S L Orloff; J A Nelson
Journal:  J Nutr       Date:  2001-10       Impact factor: 4.798

9.  A novel human cytomegalovirus locus modulates cell type-specific outcomes of infection.

Authors:  Mahadevaiah Umashankar; Alex Petrucelli; Louis Cicchini; Patrizia Caposio; Craig N Kreklywich; Michael Rak; Farah Bughio; Devorah C Goldman; Kimberly L Hamlin; Jay A Nelson; William H Fleming; Daniel N Streblow; Felicia Goodrum
Journal:  PLoS Pathog       Date:  2011-12-29       Impact factor: 6.823

10.  Simple and highly efficient BAC recombineering using galK selection.

Authors:  Søren Warming; Nina Costantino; Donald L Court; Nancy A Jenkins; Neal G Copeland
Journal:  Nucleic Acids Res       Date:  2005-02-24       Impact factor: 16.971

View more
  22 in total

1.  Human Cytomegalovirus UL135 and UL136 Genes Are Required for Postentry Tropism in Endothelial Cells.

Authors:  Farah Bughio; Mahadevaiah Umashankar; Jean Wilson; Felicia Goodrum
Journal:  J Virol       Date:  2015-04-15       Impact factor: 5.103

2.  Viral DNA Binding to NLRC3, an Inhibitory Nucleic Acid Sensor, Unleashes STING, a Cyclic Dinucleotide Receptor that Activates Type I Interferon.

Authors:  Xin Li; Meng Deng; Alex S Petrucelli; Cheng Zhu; Jinyao Mo; Lu Zhang; Jason W Tam; Pablo Ariel; Baoyu Zhao; Song Zhang; Hengming Ke; Pingwei Li; Nikolay V Dokholyan; Joseph A Duncan; Jenny P-Y Ting
Journal:  Immunity       Date:  2019-03-19       Impact factor: 31.745

3.  Overlapping transcription structure of human cytomegalovirus UL140 and UL141 genes.

Authors:  Yanping Ma; Mali Li; Bo Zheng; Ning Wang; Shuang Gao; Lin Wang; Ying Qi; Zhengrong Sun; Qiang Ruan
Journal:  J Biosci       Date:  2013-03       Impact factor: 1.826

4.  Human Cytomegalovirus Requires Epidermal Growth Factor Receptor Signaling To Enter and Initiate the Early Steps in the Establishment of Latency in CD34+ Human Progenitor Cells.

Authors:  Jung Heon Kim; Donna Collins-McMillen; Jason C Buehler; Felicia D Goodrum; Andrew D Yurochko
Journal:  J Virol       Date:  2017-02-14       Impact factor: 5.103

5.  Human Cytomegalovirus Latency: Approaching the Gordian Knot.

Authors:  Felicia Goodrum
Journal:  Annu Rev Virol       Date:  2016-08-04       Impact factor: 10.431

6.  Antagonistic determinants controlling replicative and latent states of human cytomegalovirus infection.

Authors:  Mahadevaiah Umashankar; Michael Rak; Farah Bughio; Patricia Zagallo; Katie Caviness; Felicia D Goodrum
Journal:  J Virol       Date:  2014-03-12       Impact factor: 5.103

7.  Long and Short Isoforms of the Human Cytomegalovirus UL138 Protein Silence IE Transcription and Promote Latency.

Authors:  Song Hee Lee; Katie Caviness; Emily R Albright; Jeong-Hee Lee; Christopher B Gelbmann; Mike Rak; Felicia Goodrum; Robert F Kalejta
Journal:  J Virol       Date:  2016-09-29       Impact factor: 5.103

8.  Inflammasome-independent role of AIM2 in suppressing colon tumorigenesis via DNA-PK and Akt.

Authors:  Justin E Wilson; Alex S Petrucelli; Liang Chen; A Alicia Koblansky; Agnieszka D Truax; Yoshitaka Oyama; Arlin B Rogers; W June Brickey; Yuli Wang; Monika Schneider; Marcus Mühlbauer; Wei-Chun Chou; Brianne R Barker; Christian Jobin; Nancy L Allbritton; Dale A Ramsden; Beckley K Davis; Jenny P Y Ting
Journal:  Nat Med       Date:  2015-06-24       Impact factor: 53.440

Review 9.  Human Cytomegalovirus Host Interactions: EGFR and Host Cell Signaling Is a Point of Convergence Between Viral Infection and Functional Changes in Infected Cells.

Authors:  Byeong-Jae Lee; Chan-Ki Min; Meaghan Hancock; Daniel N Streblow; Patrizia Caposio; Felicia D Goodrum; Andrew D Yurochko
Journal:  Front Microbiol       Date:  2021-05-07       Impact factor: 5.640

10.  Cis and trans acting factors involved in human cytomegalovirus experimental and natural latent infection of CD14 (+) monocytes and CD34 (+) cells.

Authors:  Cyprian C Rossetto; Margaret Tarrant-Elorza; Gregory S Pari
Journal:  PLoS Pathog       Date:  2013-05-23       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.